Literature DB >> 10800066

Bronchoalveolar lavage in the diagnosis of pulmonary complications of bone marrow transplant patients.

A J Huaringa1, F J Leyva, J Signes-Costa, R C Morice, I Raad, A A Darwish, R E Champlin.   

Abstract

Bronchoalveolar lavage (BAL) has proved valuable in the diagnosis of pulmonary complications in immunosuppressed patients. We evaluated the diagnostic yield of BAL in pulmonary complications in bone marrow transplantation (BMT) recipients. We reviewed sequentially the records of 89 patients during an 18-month period. BAL was diagnostic in 42 patients (47%). The most common pulmonary complication diagnosed by BAL was diffuse alveolar hemorrhage (n = 15); followed by bacterial pneumonia (n = 10), respiratory syncytial virus (n = 8), aspergillosis (n = 6), Pneumocystis carinii pneumonia (n = 5), cytomegalovirus (CMV) (n = 4), and others (n = 4). The final diagnoses in the BAL non-diagnostic group were: bacterial pneumonia (n = 6), CMV (n = 6), idiopathic pneumonia syndrome (n = 5), cancer recurrence (n = 4), cardiogenic pulmonary edema (n = 4), and others (n = 9). We conclude that BAL is a useful diagnostic tool in BMT-related pulmonary complications.

Entities:  

Mesh:

Year:  2000        PMID: 10800066     DOI: 10.1038/sj.bmt.1702335

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  14 in total

1.  Low-, medium- and high-dose steroids with or without aminocaproic acid in adult hematopoietic SCT patients with diffuse alveolar hemorrhage.

Authors:  N K Rathi; A R Tanner; A Dinh; W Dong; L Feng; J Ensor; S K Wallace; S A Haque; G Rondon; K J Price; U Popat; J L Nates
Journal:  Bone Marrow Transplant       Date:  2014-12-22       Impact factor: 5.483

2.  Pulmonary Complications of Pediatric Hematopoietic Cell Transplantation. A National Institutes of Health Workshop Summary.

Authors:  Robert F Tamburro; Kenneth R Cooke; Stella M Davies; Samuel Goldfarb; James S Hagood; Ashok Srinivasan; Marie E Steiner; Dennis Stokes; Nancy DiFronzo; Nahed El-Kassar; Nonniekaye Shelburne; Aruna Natarajan
Journal:  Ann Am Thorac Soc       Date:  2021-03

3.  Successful pulmonary administration of activated recombinant factor VII in diffuse alveolar hemorrhage.

Authors:  Lars Heslet; Jorn Dalsgaard Nielsen; Marcel Levi; Henrik Sengeløv; Pär I Johansson
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

4.  Treatment of diffuse alveolar hemorrhage secondary to lupus erythematosus with recombinant activated factor VII administered with a jet nebulizer.

Authors:  Raúl Carrillo Esper; Isis Espinoza de Los Monteros Estrada; Teresa de la Torre León; Agustín Omar Rosales Gutiérrez; Jorge Arturo Nava López
Journal:  J Intensive Care       Date:  2014-08-27

5.  Treatment of diffuse alveolar hemorrhage in systemic lupus erythematosus patient with local pulmonary administration of factor VIIa (rFVIIa): a case report.

Authors:  Iehab B Alabed
Journal:  Medicine (Baltimore)       Date:  2014-09       Impact factor: 1.889

Review 6.  Management of neutropenic patients in the intensive care unit (NEWBORNS EXCLUDED) recommendations from an expert panel from the French Intensive Care Society (SRLF) with the French Group for Pediatric Intensive Care Emergencies (GFRUP), the French Society of Anesthesia and Intensive Care (SFAR), the French Society of Hematology (SFH), the French Society for Hospital Hygiene (SF2H), and the French Infectious Diseases Society (SPILF).

Authors:  David Schnell; Elie Azoulay; Dominique Benoit; Benjamin Clouzeau; Pierre Demaret; Stéphane Ducassou; Pierre Frange; Matthieu Lafaurie; Matthieu Legrand; Anne-Pascale Meert; Djamel Mokart; Jérôme Naudin; Frédéric Pene; Antoine Rabbat; Emmanuel Raffoux; Patricia Ribaud; Jean-Christophe Richard; François Vincent; Jean-Ralph Zahar; Michael Darmon
Journal:  Ann Intensive Care       Date:  2016-09-15       Impact factor: 6.925

7.  Use of intrapulmonary administration of thrombin in hematological malignancy patients with alveolar haemorrhage: A case series.

Authors:  Jongmin Lee; Chin Kook Rhee; Seok Chan Kim; Young Kyoon Kim; Hee Je Kim; Seok Lee; Seok-Goo Cho; Jong Wook Lee
Journal:  Medicine (Baltimore)       Date:  2020-05       Impact factor: 1.889

8.  Intrapulmonary administration of recombinant activated factor VII in diffuse alveolar haemorrhage: a report of two case stories.

Authors:  Angel Estella; Antonio Jareño; Luis Perez-Bello Fontaiña
Journal:  Cases J       Date:  2008-09-12

9.  Transbronchial biopsy in the management of pulmonary complications of hematopoietic stem cell transplantation.

Authors:  D N O'Dwyer; A S Duvall; M Xia; T C Hoffman; K S Bloye; C A Bulte; X Zhou; S Murray; B B Moore; G A Yanik
Journal:  Bone Marrow Transplant       Date:  2017-10-23       Impact factor: 5.483

10.  Pilot trial of a novel two-step therapy protocol using nebulized tranexamic acid and recombinant factor VIIa in children with intractable diffuse alveolar hemorrhage.

Authors:  Hind Bafaqih; May Chehab; Suliman Almohaimeed; Farah Thabet; Abdulrahman Alhejaily; Mohammed AlShahrani; Mohammed A Zolaly; Abeer A Abdelmoneim; Ehab S Abd
Journal:  Ann Saudi Med       Date:  2015 May-Jun       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.